HK Stock Market Move | CHERY AUTO (09973) rose more than 4% in the afternoon, and the X-Niu S solid state battery module made its debut. The first batch of vehicle verification will be completed in 27 years.
Chery Automobile (09973) rose more than 4% in the afternoon, as of the time of writing, it has increased by 3.01% to HK$32.14, with a transaction amount of HK$1.11 billion.
CHERY AUTO (09973) rose more than 4% in the afternoon, with a 3.01% increase as of the time of writing, reaching HK$32.14, with a turnover of HK$1.11 billion.
On the news front, on October 18th, CHERY AUTO announced at the 2025 Chery Global Innovation Conference that Chery has achieved a breakthrough in solid-state battery technology across the entire industry chain and showcased the Rhinoceros S solid-state battery module. After installation, the electric vehicle's range will increase to 1200-1300 kilometers. It is reported that the Rhinoceros S solid-state battery will complete the first batch of vehicle installation verification by 2027, achieving real vehicle carrying and performance testing, laying the foundation for mass production.
In addition, CHERY AUTO announced that on October 22nd, the overall coordinator exercised part of the excess allotment rights, involving a total of 41.3759 million shares, accounting for approximately 13.91% of the total number of shares sold. Priced at HK$30.75 per share, the additional net proceeds were HK$1.249 billion. Furthermore, the stabilizing price period for the global offering ended on the same day. During the period, the stabilizing price manager, China International Finance, continued to purchase a total of 3.2336 million shares at prices ranging from HK$30.42 to HK$30.74 per share.
Related Articles

Jiangsu Hengrui Pharmaceuticals (01276): Injection of \(derived\) single-antibody \(drug\) approved to conduct clinical trials.

Northbound funds | Northbound trading volume reached a net buying of 5.345 billion yuan, with Europe and America adding sanctions on Russian oil. Northbound trading also increased its position in CNOOC (00883) by nearly 1 billion Hong Kong dollars.

YAN PALACE (01497) spent 810,000 Hong Kong dollars to repurchase 100,000 shares on October 23rd.
Jiangsu Hengrui Pharmaceuticals (01276): Injection of \(derived\) single-antibody \(drug\) approved to conduct clinical trials.

Northbound funds | Northbound trading volume reached a net buying of 5.345 billion yuan, with Europe and America adding sanctions on Russian oil. Northbound trading also increased its position in CNOOC (00883) by nearly 1 billion Hong Kong dollars.

YAN PALACE (01497) spent 810,000 Hong Kong dollars to repurchase 100,000 shares on October 23rd.

RECOMMEND

Why European Automakers Are Opposing Dutch Sanctions
20/10/2025

Domestic Commercial Rockets Enter Batch Launch Era: Behind the Scenes a Sixfold Cost Gap and Reusability as the Key Breakthrough
20/10/2025

Multiple Positive Catalysts Lift Tech Stocks; UBS Elevates China Tech to Most Attractive, Citing AI as Core Rationale
20/10/2025